Clinical data suggests olaparib, approved for ovarian cancer, may be effective for rare, childhood brain cancer: https://t.co/tuSmdzLnrx

Clinical data suggests olaparib, approved for ovarian cancer, may be effective for rare, childhood brain cancer: https://t.co/tuSmdzLnrx

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://twitter.com/ecancer/status/826869053348311043
via IFTTT